修正“人参皂苷20（S）-Rg3上调HIF-1α-靶向miR-519a-5p以抑制卵巢癌症细胞中的Warburg效应”。

IF 2.9 4区医学 Q2 Medicine

Clinical and Experimental Pharmacology and Physiology Pub Date : 2023-11-02 DOI:10.1111/1440-1681.13827

{"title":"修正“人参皂苷20（S）-Rg3上调HIF-1α-靶向miR-519a-5p以抑制卵巢癌症细胞中的Warburg效应”。","authors":"","doi":"10.1111/1440-1681.13827","DOIUrl":null,"url":null,"abstract":"Lu J, Chen H, He F, et al. Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells. Clin Exp Pharmacol Physiol. 2020;47(8):1455-1463.The Western blot image of β-actin in the right panel of Figure 4A had been misplaced by the Western blot image of β-actin in the right panel of Figure 7A during figure assembly.We apologize for this error.","PeriodicalId":50684,"journal":{"name":"Clinical and Experimental Pharmacology and Physiology","volume":"50 12","pages":"1005"},"PeriodicalIF":2.9000,"publicationDate":"2023-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correction to “Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells”\",\"authors\":\"\",\"doi\":\"10.1111/1440-1681.13827\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Lu J, Chen H, He F, et al. Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells. Clin Exp Pharmacol Physiol. 2020;47(8):1455-1463.The Western blot image of β-actin in the right panel of Figure 4A had been misplaced by the Western blot image of β-actin in the right panel of Figure 7A during figure assembly.We apologize for this error.\",\"PeriodicalId\":50684,\"journal\":{\"name\":\"Clinical and Experimental Pharmacology and Physiology\",\"volume\":\"50 12\",\"pages\":\"1005\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2023-11-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Pharmacology and Physiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/1440-1681.13827\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Pharmacology and Physiology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1440-1681.13827","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

陆军，陈华，何峰，等。人参皂苷20(S)-Rg3上调hif -1α-靶向miR-519a-5p抑制卵巢癌细胞中的Warburg效应。中华临床医学杂志，2020;47(8):1455-1463。图4A右图中β-actin蛋白的Western blot图像在拼装过程中被图7A右图中β-actin蛋白的Western blot图像错位。我们为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Correction to “Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells”

查看原文本刊更多论文

Correction to “Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells”

Lu J, Chen H, He F, et al. Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells. Clin Exp Pharmacol Physiol. 2020;47(8):1455-1463.

The Western blot image of β-actin in the right panel of Figure 4A had been misplaced by the Western blot image of β-actin in the right panel of Figure 7A during figure assembly.

We apologize for this error.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical and Experimental Pharmacology and Physiology 医学-生理学

CiteScore

6.20

自引率

0.00%

发文量

128

审稿时长

6 months

期刊介绍： Clinical and Experimental Pharmacology and Physiology is an international journal founded in 1974 by Mike Rand, Austin Doyle, John Coghlan and Paul Korner. Our focus is new frontiers in physiology and pharmacology, emphasizing the translation of basic research to clinical practice. We publish original articles, invited reviews and our exciting, cutting-edge Frontiers-in-Research series’.